- Home
- ALCYU vs MRK Comparison
ALCYU vs MRK Comparison
Compare ALCYU & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCYU
- MRK
- Stock Information
- Founded
- ALCYU N/A
- MRK 2000
- Country
- ALCYU
- MRK United States
- Employees
- ALCYU 3
- MRK N/A
- Industry
- ALCYU
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- ALCYU
- MRK Health Care
- Exchange
- ALCYU NYSE
- MRK Nasdaq
- Market Cap
- ALCYU N/A
- MRK 198.5B
- IPO Year
- ALCYU N/A
- MRK N/A
- Fundamental
- Price
- ALCYU N/A
- MRK $81.00
- Analyst Decision
- ALCYU
- MRK Buy
- Analyst Count
- ALCYU 0
- MRK 15
- Target Price
- ALCYU N/A
- MRK $113.71
- AVG Volume (30 Days)
- ALCYU N/A
- MRK 18.0M
- Earning Date
- ALCYU N/A
- MRK 07-29-2025
- Dividend Yield
- ALCYU N/A
- MRK 4.00%
- EPS Growth
- ALCYU N/A
- MRK 667.14
- EPS
- ALCYU N/A
- MRK 6.88
- Revenue
- ALCYU N/A
- MRK $63,922,000,000.00
- Revenue This Year
- ALCYU N/A
- MRK $2.42
- Revenue Next Year
- ALCYU N/A
- MRK $5.77
- P/E Ratio
- ALCYU N/A
- MRK $11.77
- Revenue Growth
- ALCYU N/A
- MRK 4.10
- 52 Week Low
- ALCYU N/A
- MRK $73.31
- 52 Week High
- ALCYU N/A
- MRK $129.93
- Technical
- Relative Strength Index (RSI)
- ALCYU 43.55
- MRK 54.36
- Support Level
- ALCYU $11.36
- MRK $78.14
- Resistance Level
- ALCYU $12.00
- MRK $83.07
- Average True Range (ATR)
- ALCYU 0.00
- MRK 1.84
- MACD
- ALCYU 0.00
- MRK 0.21
- Stochastic Oscillator
- ALCYU 0.00
- MRK 64.15
About ALCYU ALCHEMY INVTS ACQUISITION CORP 1 UNIT 1 CL A COM & 1/2 WT
Alchemy Investments Acquisition Corp 1 is a blank check company.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.